Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST001832)

(Analysis AN002974)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15	F16	F17	F18
Glycodeoxycholic Acid	ME423598	0.35	0.31	0.39	0.70	0.33	0.09	0.06	0.22	0.21	0.73	0.12	0.62	1.54	0.47	0.24	0.06	1.20	8.98
Glycoursodeoxycholic Acid	ME423600	0.19	0.07	0.18	0.22	0.20	0.12	0.03	0.13	0.15	0.84	0.02	0.73	0.69	0.49	0.58	0.02	3.24	7.23
Glycochenodeoxycholic Acid	ME423597	0.16	0.15	0.09	0.29	0.17	0.12	0.03	0.28	0.13	0.45	0.16	0.46	0.56	0.36	0.34	0.13	2.41	6.02
Glycocholic Acid	ME423596	0.09	0.33	0.11	0.18	0.10	0.05	0.05	0.51	0.16	1.04	0.19	0.97	1.12	0.92	0.63	0.06	2.61	5.36
ω-Muricholic Acid	ME423605	2.44	0.64	2.86	6.42	2.11	2.01	0.20	0.44	1.42	0.01	0.00	0.01	0.02	0.00	0.02	0.00	0.01	0.05
Hyodeoxycholic Acid	ME423601	3.07	0.08	4.04	5.23	3.65	1.64	0.02	0.07	0.43	0.02	0.01	0.02	0.03	0.01	0.03	0.01	0.01	0.10
Chenodeoxycholic Acid	ME423594	4.71	0.18	3.32	5.48	3.51	1.69	0.02	0.03	0.98	0.01	0.00	0.01	0.02	0.00	0.01	0.00	0.01	0.06
Deoxycholic Acid	ME423595	4.21	0.50	4.31	5.02	3.26	1.84	0.50	0.02	0.74	0.02	0.01	0.01	0.03	0.01	0.02	0.01	0.02	0.05
Glycolithocholic Acid	ME423599	1.24	0.74	1.44	1.48	0.98	0.95	0.37	0.68	0.96	0.58	0.92	0.55	0.86	0.89	0.49	0.55	0.37	2.26
Taurolithocholic Acid	ME423609	1.38	1.57	1.44	3.45	1.39	0.70	0.22	1.38	0.90	0.60	0.60	0.45	0.73	0.67	0.76	0.22	0.74	1.06
β-Muricholic Acid	ME423604	1.93	2.54	2.68	3.55	2.18	1.05	1.15	1.65	1.25	0.02	0.03	0.02	0.02	0.01	0.06	0.01	0.05	0.10
Lithocholic Acid	ME423602	1.57	0.18	2.01	2.08	1.97	1.52	0.09	0.70	0.60	0.00	0.01	0.00	0.05	0.00	0.01	NA	NA	0.04
Ursodeoxycholic Acid	ME423612	2.68	0.01	2.74	3.50	2.59	1.58	NA	0.02	0.49	0.05	0.00	0.06	0.04	0.02	0.05	NA	0.12	0.15
α-Muricholic Acid	ME423603	0.46	2.94	0.44	0.82	0.40	1.58	4.14	3.49	3.69	0.03	0.04	0.02	0.01	0.03	0.08	0.00	0.03	0.23
Taurodeoxycholic Acid	ME423608	0.64	2.84	0.80	2.56	0.37	0.09	0.11	0.17	0.13	1.29	1.26	1.79	1.12	1.36	0.83	0.40	2.64	1.07
Taurochenodeoxycholic Acid	ME423607	0.07	1.06	0.22	0.30	0.26	0.11	0.20	1.70	0.14	0.63	1.84	1.44	0.46	1.75	1.41	1.31	2.40	2.20
Tauroursodeoxycholic Acid	ME423611	0.37	0.73	0.83	1.06	0.48	0.21	0.08	0.83	0.16	1.46	0.41	2.12	0.54	2.16	1.42	0.17	2.06	2.00
Cholic Acid	ME423593	0.81	3.34	1.61	1.67	1.56	0.18	1.20	3.40	0.50	0.47	0.03	0.30	0.34	0.23	0.51	0.02	0.15	1.14
Taurocholic Acid	ME423606	0.10	2.98	0.39	0.26	0.17	0.04	0.63	2.53	1.16	0.77	1.56	1.55	0.43	1.62	0.66	0.84	1.28	1.06
α-β-Tauromuricholic Acid	ME423610	0.52	5.48	0.57	0.77	0.39	0.16	0.55	1.99	0.73	0.47	1.44	1.38	0.34	1.09	1.03	1.15	1.40	1.60

Factors:

F1	Tissue:Caecum \| Sample treatment:DIO
F2	Tissue:Caecum \| Sample treatment:DIO_AB
F3	Tissue:Caecum \| Sample treatment:DIO_FMT_RYGB
F4	Tissue:Caecum \| Sample treatment:DIO_PF_FMT
F5	Tissue:Caecum \| Sample treatment:FMT_lean
F6	Tissue:Caecum \| Sample treatment:Lean
F7	Tissue:Caecum \| Sample treatment:Lean_AB
F8	Tissue:Caecum \| Sample treatment:RYGB_AB
F9	Tissue:Caecum \| Sample treatment:RYGB_Donor
F10	Tissue:Serum \| Sample treatment:DIO
F11	Tissue:Serum \| Sample treatment:DIO_AB
F12	Tissue:Serum \| Sample treatment:DIO_FMT_RYGB
F13	Tissue:Serum \| Sample treatment:DIO_PF_FMT
F14	Tissue:Serum \| Sample treatment:FMT_lean
F15	Tissue:Serum \| Sample treatment:Lean
F16	Tissue:Serum \| Sample treatment:Lean_AB
F17	Tissue:Serum \| Sample treatment:RYGB_AB
F18	Tissue:Serum \| Sample treatment:RYGB_Donor

Data matrix